125 related articles for article (PubMed ID: 38153696)
1. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
Pan C; Wang Q; Wang H; Deng X; Chen L; Li Z
Carcinogenesis; 2024 May; 45(5):311-323. PubMed ID: 38153696
[TBL] [Abstract][Full Text] [Related]
2. Identification of LncRNA CARD8-AS1 as a Potential Prognostic Biomarker Associated With Progression of Lung Adenocarcinoma.
Ji Y; Zhang G; Zhang X
Br J Biomed Sci; 2022; 79():10498. PubMed ID: 35996500
[No Abstract] [Full Text] [Related]
3. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.
Kang H; Ma D; Zhang J; Zhao J; Yang M
BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
Liu T; Yang C; Wang W; Liu C
Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MAFG-AS1 Promotes Lung Adenocarcinoma Cell Migration and Invasion by Targeting miR-3196 and Regulating SOX12 Expression.
Wu Q; Jiang J
Mol Biotechnol; 2022 Sep; 64(9):970-983. PubMed ID: 35275356
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
10. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
Wang M; Liao Q; Zou P
Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
[TBL] [Abstract][Full Text] [Related]
12. ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.
Ying K; Wang L; Long G; Lian C; Chen Z; Lin W
Cell Biol Int; 2020 Dec; 44(12):2438-2449. PubMed ID: 32808728
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
[No Abstract] [Full Text] [Related]
14. Upregulation of LINC01426 promotes the progression and stemness in lung adenocarcinoma by enhancing the level of SHH protein to activate the hedgehog pathway.
Liu X; Yin Z; Xu L; Liu H; Jiang L; Liu S; Sun X
Cell Death Dis; 2021 Feb; 12(2):173. PubMed ID: 33568633
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ZFPM2-AS1 is involved in lung adenocarcinoma via miR-511-3p/AFF4 pathway.
Li J; Ge J; Yang Y; Liu B; Zheng M; Shi R
J Cell Biochem; 2020 Mar; 121(3):2534-2542. PubMed ID: 31692047
[TBL] [Abstract][Full Text] [Related]
16. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
Xiao G; Wang P; Zheng X; Liu D; Sun X
Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
[TBL] [Abstract][Full Text] [Related]
17. ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis.
Wang B; Cai Y; Li X; Kong Y; Fu H; Zhou J
Cell Cycle; 2021 Dec; 20(24):2607-2618. PubMed ID: 34850664
[TBL] [Abstract][Full Text] [Related]
18. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis.
Liu Y; Liang L; Ji L; Zhang F; Chen D; Duan S; Shen H; Liang Y; Chen Y
Aging (Albany NY); 2021 Oct; 13(19):23376-23392. PubMed ID: 34644678
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an endoplasmic reticulum stress-associated lncRNA prognostic signature and the tumor-suppressive role of RP11-295G20.2 knockdown in lung adenocarcinoma.
Yu L; Zhou S; Hong W; Lin N; Wang Q; Liang P
Sci Rep; 2024 May; 14(1):12283. PubMed ID: 38811828
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
Hu Z; Zhu L; Zhang Y; Chen B
Bioengineered; 2022 Feb; 13(2):3093-3107. PubMed ID: 35068325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
